3 Contenders To Be The First Profitable Stem Cell Company
By Ryan Pollack, SeekingAlpha.com Every day is a day closer to a disease being treated, or even cured, by a stem cell therapy. The medical field is… Read more »
The Promising Cells Presented by International Stem Cell Corporation
Ken Aldrich of International Stem Cell Corporation (ISCO.OB) speaks on the latest research involving stem cell technology utilizing unfertilized eggs, as a basis for cell generation with… Read more »
View from the Top – Kenneth Aldrich, International Stem Cell Corporation
Kenneth Aldrich, Chairman of International Stem Cell Corporation, discusses the next generation of therapeutic stem cells.
International Stem Cell Corporation Progresses towards Establishment of the Industry’s First Universal Stem Cell Bank, UniStemCell™
OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO), www.internationalstemcell.com, announced today that it has signed up the first two in vitro fertilization (IVF) clinics and engaged an… Read more »
International Stem Cell Corporation and Absorption Systems Announce Potential Stem Cell Alternative to Live Animal Testing for Corneal Damage
OCEANSIDE, Calif. & EXTON, Pa.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB:ISCO)), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, announces… Read more »
Video – International Stem Cell Corporation CEO Ken Aldrich
International Stem Cell Corporation is a California company that has developed breakthrough human stem cell lines that promise to eliminate the rejection of transplanted cells by the… Read more »
International Stem Cell Begins Pre-Clinical Testing of Its Parthenogenetic Stem Cells for Treatment of Retinal Disease
First Company To Grow Human Corneal Tissue From Stem Cells Oceanside, California, January 13, 2009 — International Stem Cell Corporation (OTCBB: ISCO) has created layered human tissue… Read more »